Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 19, 2021 08:00 ET | Source: Brooklyn Immunotherapeutics LLC

Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics

Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today, July 19, 2021, at 4:15PM ET to Discuss the...
June 14, 2021 07:30 ET | Source: Brooklyn Immunotherapeutics LLC

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene...